The Effectivity and Safety of Favipiravir Compared to Oseltamivir as Adjuvant Therapy for COVID-19: An Open Label Trial
Latest Information Update: 05 Sep 2022
At a glance
- Drugs Favipiravir (Primary) ; Antipyretics; Ascorbic acid; Azithromycin; Chloroquine; Chloroquine diphosphate; Hydroxychloroquine; Levofloxacin; Oseltamivir
- Indications COVID 2019 infections
- Focus Therapeutic Use
- 23 Sep 2020 New trial record